Your browser doesn't support javascript.
loading
Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng, Huan; Hang, Qingqing; Shen, Dijian; Zhang, Yibi; Chen, Ming.
Afiliação
  • Deng H; College of Life Sciences, University of the Chinese Academy of Sciences, Beijing, 100049, China.
  • Hang Q; Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, 310022, China.
  • Shen D; Institute of Cancer Research and Basic Medical (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, China.
  • Zhang Y; Department of Radiation Oncology, Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, China.
  • Chen M; Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, 310022, China.
Cancer Cell Int ; 21(1): 259, 2021 May 12.
Article em En | MEDLINE | ID: mdl-33980221
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article